Protein profile

KP13_02415

Bifunctional T-protein

Genome: KpKP13

Gene: AHE43148.1 tyrA Structure source: AlphaFold + ColabFold UniProt A0A0H3GRW1
Amino acids 373
Annotations 7
Features 30
PDB binders 2
Druggability 0.844

Overview

Basic information about this protein and its source genome.

Accession
KP13_02415
Gene
AHE43148.1 tyrA
Status
annotated
Amino acids
373
Structure source
AlphaFold + ColabFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Human identity (%)
0.0
Gut microbiome off-target
hit
Essential (DEG)
N
DEG identity (%)
0.0
Localization
Cytoplasmic
ColabFold pLDDT
94.0

Selected Druggability evidence

AlphaFold / UniProt model

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.844
Structure A0A0H3GRW1
Pocket Pocket 13
P2Rank 0.57
Structure A0A0H3GRW1
Pocket Pocket 1
ColabFold model
FPocket 0.766 · Pocket 36
P2Rank 0.677 · Pocket 1
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 141 / 4744 genomes with a hit
Normalized 0.03

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

7 GO

Gene Ontology (GO)

7
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
  • GO:0004665 Catalysis of the reaction: NADP+ + prephenate = (4-hydroxyphenyl)pyruvate + CO2 + NADPH.
  • GO:0006571 The chemical reactions and pathways resulting in the formation of tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid.
  • GO:0070403 Binding to the oxidized form, NAD, of nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions.
  • GO:0046417 The chemical reactions and pathways involving chorismate, the anion of (3R-trans)-3-((1-carboxyethenyl)oxy)-4-hydroxy-1,5-cyclohexadiene-1-carboxylic acid.
  • GO:0004106 Catalysis of the reaction: chorismate = prephenate.
  • GO:0008977 Catalysis of the reaction: NAD+ + prephenate = (4-hydroxyphenyl)pyruvate + CO2 + NADH.

Sequence Features

Domain/signature hits from InterPro and related databases.

30 records
Show feature table
Start End DB Term Name
137 219 Pfam PF02153 Prephenate dehydrogenase, nucleotide-binding domain
137 219 InterPro IPR046826 Prephenate dehydrogenase, nucleotide-binding domain
82 246 FunFam G3DSA:3.40.50.720:FF:000170 T-protein
241 366 SUPERFAMILY SSF48179 6-phosphogluconate dehydrogenase C-terminal domain-like
241 366 InterPro IPR008927 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
91 238 SUPERFAMILY SSF51735 NAD(P)-binding Rossmann-fold domains
91 238 InterPro IPR036291 NAD(P)-binding domain superfamily
248 373 FunFam G3DSA:1.10.3660.10:FF:000001 T-protein
1 90 ProSiteProfiles PS51168 Chorismate mutase domain profile.
1 90 InterPro IPR002701 Chorismate mutase II, prokaryotic-type
5 87 NCBIfam TIGR01799 chorismate mutase
5 87 InterPro IPR011277 Chorismate mutase, T-protein
82 246 Gene3D G3DSA:3.40.50.720 -
243 344 Pfam PF20463 Prephenate dehydrogenase, dimerization domain
243 344 InterPro IPR046825 Prephenate dehydrogenase, dimerization domain
1 373 PIRSF PIRSF001499 Chor_mut_pdh_Tpr
1 373 InterPro IPR008244 Bifunctional chorismate mutase/prephenate dehydrogenase T-protein
4 88 SUPERFAMILY SSF48600 Chorismate mutase II
4 88 InterPro IPR036263 Chorismate mutase type II superfamily
99 361 ProSiteProfiles PS51176 Prephenate/arogenate dehydrogenase domain profile.
99 361 InterPro IPR003099 Prephenate dehydrogenase
9 86 Pfam PF01817 Chorismate mutase type II
9 86 InterPro IPR002701 Chorismate mutase II, prokaryotic-type
248 373 Gene3D G3DSA:1.10.3660.10 -
2 81 Gene3D G3DSA:1.20.59.10 Chorismate mutase
2 81 InterPro IPR036979 Chorismate mutase domain superfamily
96 372 PANTHER PTHR21363 PREPHENATE DEHYDROGENASE
9 89 SMART SM00830 CM_2_4
9 89 InterPro IPR002701 Chorismate mutase II, prokaryotic-type
2 81 FunFam G3DSA:1.20.59.10:FF:000001 T-protein

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 2

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold AF_A0A0H3GRW1
AlphaFold full sequence Viewing
ColabFold KP13_02415
ColabFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
13 0.844
34 0.393

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 7.48 0.393
2 4.38 0.184
3 2.51 0.07
4 1.78 0.033
5 1.5 0.021

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

52 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
MLT A0A0H3LYP5 134.1 Da LogP -1.09 TPSA 94.8 ✓ Ro5 ✓ Clean C([C@H](C(=O)O)O)C(=O)O
TSA Q57696 228.2 Da LogP -0.38 TPSA 104.1 ✓ Ro5 ✓ Clean C1[C@@H]2[C@@H](C=C[C@]1(C[C@H](O2)C(=O)O)C(=O)…

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.